文献速递鼻科睡眠呼吸障碍

复发性慢性鼻窦炎伴鼻息肉合并哮喘不同内镜手术的5年结局

Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma.
PubMed 文献 · Rhinology · 2020-01-01

RESS与RESS+Draf 3短期(1年)结局优于FESS,5年复发率各组均高(95.6–96.1%);RESS与RESS+Draf 3长期修正手术率更低、复发时间更长,且与组织及外周血嗜酸性粒细胞百分比负相关。RESS+Draf 3未优于RESS单用。

要点

  • RESS与RESS+Draf 3短期结局优于FESS,但5年复发率各组均达95.6–96.1%。
  • RESS与RESS+Draf 3较FESS长期修正手术率更低、复发时间更长。
  • 复发时间与组织和外周血嗜酸性粒细胞百分比呈负相关。

核心结论

  • CRSwNP合并哮喘是系统性疾病,术后不可避免复发。
  • 根治性手术可延长复发时间并在短期改善嗅觉、流涕和生活质量。
  • RESS联合Draf 3未较RESS单用带来更优临床结局,RESS单用可能为最佳选择但需进一步研究确认。

研究设计与样本

  • 患者随机分配接受FESS、RESS或RESS+Draf 3手术。
  • 采用症状评分、内镜评分、CT分期、鼻窦特异性生活质量评分、组织和外周血嗜酸性粒细胞百分比及肺功能检查评估。
  • 比较基线、1年、3年和5年随访数据。

主要发现

  • RESS和RESS+Draf 3短期(1年)结局优于FESS。
  • FESS短期复发率更高,但5年术后复发率各组均高(95.6–96.1%)。
  • RESS和RESS+Draf 3较FESS长期修正手术率更低、术后复发时间更长。
  • 复发时间与组织和外周血嗜酸性粒细胞百分比呈负相关。

临床怎么用

  • 对复发性CRSwNP合并哮喘患者,RESS可能较FESS减少长期修正手术并延长复发时间。
  • RESS联合Draf 3未显示额外获益,选择术式时需权衡。
  • 组织和外周血嗜酸性粒细胞百分比可能有助于预判复发时间。

局限性

  • 随访时间仍需更长。
  • 需更严格标准化药物治疗,尤其是充分激素冲洗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma have poorer outcomes after functional endoscopic sinus surgery (FESS) and higher recurrence rate. The aim of present study was to investigate the long-term clinical outcomes of extended surgical strategies for patients with recurrent CRSwNP and asthma. METHODS: Eighty-one patients with CRSwNP and asthma were enrolled in this 5-year prospective study. They were randomly assigned to undergo FESS, radical endoscopic sinus surgery (RESS), or RESS+Draf 3 surgery. Disease severity and clinical outcomes were evaluated using symptoms scoring, endoscopic scoring system, computed tomography staging system, sinus-specific quality of life scores, tissue and peripheral blood eosinophil percentage, and pulmonary function tests. Baseline, 1-year, 3-year, and 5-year follow-up data were compared among the groups. RESULTS: RESS and RESS+Draf 3 strategies yielded better short-term (1 year) outcomes than did FESS. FESS had a higher short-term recurrence rate, although recurrence rates were similarly high (95.6 - 96.1%) in all the groups at 5 years postoperatively. RESS and RESS+Draf 3 yielded a lower long-term revision surgery rate and a longer time to recurrence post-surgery than FESS, which was negatively correlated with tissue and peripheral blood eosinophil percentage. CONCLUSIONS: CRSwNP with asthma is a systemic disease that inevitably recurs. Radical surgery prolongs recurrence time and improves olfaction, rhinorrhea, and quality of life in the short-term. Combining Draf 3 with RESS did not yield better clinical outcomes than RESS alone; thus, although RESS alone appears to be the best option, these findings need to be confirmed in further studies involving more patients, longer follow-up duration and stricter standardized medication use especially the adequate steroid irrigations.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Zhang L, Zhang Y, Gao Y, et al. Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma. Rhinology. 2020. PMID: 31904028. doi:10.4193/Rhin19.184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。